study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MH-LTHR-GABA_01,2013,randomized controlled trial,SMD,-0.3214,-0.4757,-0.1671,68,58,mixed,10.1234/mh-lthr-gaba-01,mental_health_journal,anxiety_management,Adults with anxiety management concerns,Transient headache,11
MH-LTHR-GABA_02,2014,randomized controlled trial,SMD,-0.3587,-0.5015,-0.2159,72,61,low,10.1234/mh-lthr-gaba-02,mental_health_journal,anxiety_management,Adults with anxiety management concerns,None reported,6
MH-LTHR-GABA_03,2015,randomized controlled trial,SMD,-0.4372,-0.5975,-0.2770,76,64,some concerns,10.1234/mh-lthr-gaba-03,mental_health_journal,anxiety_management,Adults with anxiety management concerns,Mild GI discomfort,7
